Therapy response evaluation with FDG-ET/CT in small cell lung cancer: A prognostic and comparison study of the PERCIST and EORTC criteria

Cancer Imaging

Volumn 13, Issue 1, 2013, Pages 73-80

  Ziai, D ^a,b   Wagner, T ^a   El Badaoui, A ^a   Hitzel, A ^c   Woillard, J B ^d   Melloni, B ^d   Monteil, J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Department of Radiology ^*  (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

EORTC; FDG PET CT; PERCIST; Prognosis; therapy; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LEAN BODY WEIGHT; LUNG SMALL CELL CANCER; MALE; MEDICAL DECISION MAKING; METABOLIC DISORDER; METASTASIS; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; SMALL CELL LUNG CARCINOMA;

EID: 84875516942     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2013.0008     Document Type: Article

References (12)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300. doi:10.3322/caac.20073. PMid:20610543.
2. Brink I, Schumacher T, Mix M, et al. Impact of[18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004; 31: 1614-1620. doi:10.1007/s00259-004- 1606-x. PMid:15258700. (Pubitemid 40104607)
3. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using[18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999; 35: 1773-1782. doi:10.1016/S0959- 8049(99)00229-4. PMid:10673991. (Pubitemid 29512308)
4. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50: 122S-150S. doi:10.2967/ jnumed.108.057307. PMid:19403881.
5. Eisenhauer E, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247. doi:10.1016/ j.ejca.2008.10.026. PMid:19097774.
6. Bergeri I, Michel R, Boutin JP.[Everything (or almost everything) about the Kappa coefficient]. Med Trop (Mars) 2002; 62: 634-636 (in French).
7. Azad A, Chionh F, Scott AM, et al. High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer. Mol Imaging Biol 2010; 12: 443-451. doi:10.1007/s11307-009-0295-z. PMid:19921339.
8. Yamamoto Y, Kameyama R, Murota M, Bandoh S, Ishii T, Nishiyama Y. Early assessment of therapeutic response using FDG PET in small cell lung cancer. Mol Imaging Biol 2009; 11: 467-472. doi:10.1007/s11307-009-0227-y. PMid:19434460.
9. Fischer BM, Mortensen J, Langer SW, et al. PET/CT imaging in response evaluation of patients with small cell lung cancer. Lung Cancer 2006; 54: 41-49. doi:10.1016/j.lungcan.2006.06.012. PMid:16919841.
10. Mac Manus MP, Hicks RJ, Matthews JP, et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2003; 21: 1285-1292. doi:10.1200/JCO.2003.07.054. PMid:12663716. (Pubitemid 46606405)
11. Lee YJ, Cho A, Cho BC, et al. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. Clin Cancer Res 2009; 15: 2426-2432. doi:10.1158/1078-0432.CCR-08-2258. PMid:19318478.
12. Pandit N, Gonen M, Krug L, Larson SM. Prognostic value of[18F]FDG-PET imaging in small cell lung cancer. Eur J Nucl Med Mol Imaging 2003; 30: 78-84. doi:10.1007/s00259-002- 0937-8. PMid:12483413. (Pubitemid 36692896)